Hjem › Hudlidelser › Californien
Hudlidelser kliniske forsøg i Californien
11 studier for Hudlidelser søger deltagere på steder i Californien.
Byer i Californien
Officiel studietekst (engelsk)
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- City of Hope Comprehensive Cancer Center, Duarte
- UCLA Medical Center, Los Angeles
- Stanford Cancer Institute, Stanford
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04996875Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Amicis Research Center Valencia, Northridge
- Children'S Hospital of Orange County, Orange
- Clinical Trials Research Institute, Thousand Oaks
RekruttererFase 1
Alder 12 til 75 · Alle køn · Opdateret 15. sep. 2026 · NCT07049575A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
- California Dermatology & Clinical Research Institute, Encinitas
- Dermatology Research Associates, Los Angeles
- University of California, San Diego/Rady Children's Hospital, San Diego - Pediatric & Adolescent Dermatology, San Diego
- og 2 flere
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 8. sep. 2026 · NCT05723198A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Northridge Clinical Trials, Northridge
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Marvel Research, LLC, Huntington Beach
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- og 4 flere
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 28. aug. 2026 · NCT07599813A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
- Stanford University School of Medicine, Dermatology Department, Palo Alto
RekruttererFase 2
Alder 2 og opefter · Alle køn · Opdateret 13. aug. 2026 · NCT07027345A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 1, Lancaster
- Inmagene Site 23, Los Angeles
RekruttererFase 2
Alder 18 til 74 · Alle køn · Opdateret 12. aug. 2026 · NCT07037901Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
- Center for Dermatology Clinical Research, Inc, Fremont
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 22. apr. 2026 · NCT07144852Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
- Center for Dermatology Clinical Research, Inc, Fremont
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 22. apr. 2026 · NCT07144345Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- Beckman Laser Institute and Medical Clinic, Irvine
- Dermatology Clinic at Gavin Herbert Eye Institute, Irvine
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 16 og opefter · Alle køn · Opdateret 13. apr. 2026 · NCT00842283Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 29. apr. 2022 · NCT04684602Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.